Northside Hospital Cancer Institute has offered cancer care since 1978 and has grown into one of the largest and most respected cancer care providers in the Southeast, ranking No. 46 nationally and No. 2 in Georgia for cancer care by U.S. News & World Report for 2026-27. The institute diagnoses and treats more cancer cases than any other hospital system in Georgia, handles more breast and gynecologic cancer cases than any other hospital in the Southeast, and delivers more prostate cancer treatments than any other facility in Atlanta. The institute features the most board-certified oncologists in Georgia and operates in close affiliation with Atlanta Cancer Care, which maintains multiple metro Atlanta office locations. The institute holds an “Outstanding Achievement Award” from the American College of Surgeons Commission on Cancer, along with accreditations including the national accreditation program for breast centers, the national accreditation program for rectal cancer, quality oncology practice initiative certification, and Joint Commission disease-specific certification for lung cancer. Its research program is one of the nation’s largest community-based oncology and hematology programs, and Northside is a leading partner in the Georgia NCI community oncology research program, giving patients access to cancer prevention, screening and treatment clinical trials within their communities. In May 2026, its blood and marrow transplant program treated its first mantle cell lymphoma patient in a novel therapy trial, and in September 2026, Northside expanded its robotic surgery capabilities with new da Vinci 5 systems designed to improve precision and recovery.
